Comprehensive DNA methylation analysis of hepatitis B virus genome in infected liver tissues

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Jain, Surbhi ^a   Chang, Ting Tsung ^b   Chen, Sitong ^a   Boldbaatar, Batbold ^a   Clemens, Adam ^a   Lin, Selena Y ^c   Yan, Ran ^c,e   Hu, Chi Tan ^d   Guo, Haitao ^c   Block, Timothy M ^c   Song, Wei ^a   Su, Ying Hsiu ^c  

^a JBS Science Inc   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d TZU CHI UNIVERSITY   (Taiwan)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; APC PROTEIN, HUMAN; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, HUMAN; RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; VIRUS DNA;

CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; GENETICS; GENOTYPE; HEPATITIS B VIRUS; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TUMOR; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VIROLOGY;

ADENOMATOUS POLYPOSIS COLI PROTEIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA, VIRAL; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HEPATITIS B VIRUS; HUMANS; LIVER; LIVER DISEASES; LIVER NEOPLASMS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS;

EID: 84930227190     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10478     Document Type: Article

References (48)

1. Bruix, J. & Sherman, M. Management of hepatocellular carcinoma: An update. Hepatology 53, 1020-1022 (2011).
2. European Association for the Study of the, L., European Organisation for, R. & Treatment of, C. EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol 56, 908-943 (2012).
3. Lok, A. S. F. & McMahon, B. J. Chronic hepatitis B: Update 2009. Hepatology 50, 661-662 (2009).
4. Bosch, F. X., Ribes, J., Cléries, R. & Díaz, M. Epidemiology of Hepatocellular Carcinoma. Clin. Liver. Dis. 9, 191-211 (2005).
5. World Health Organization. Hepatitis B (Fact sheet No. 204). (2013) Available at: http://www.who.int/mediacentre/factsheets/fs204/en/. (Accessed: 1st December 2015).
6. Ferlay, J. et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. (2013) Available at: http://globocan.iarc.fr. (Accessed: 23rd April 2014).
7. Kao, J. H., Chen, P. J., Lai, M. Y. & Chen, D. S. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124, 327-334 (2003).
8. Yuan, J. et al. Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications. J. Clin Virol. 39, 87-93 (2007).
9. Lindh, M., Hannoun, C., Dhillon, A. P., Norkrans, G. & Horal, P. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J. Infect. Dis. 179, 775-782 (1999).
10. Tangkijvanich, P., Sa-nguanmoo, P., Mahachai, V., Theamboonlers, A. & Poovorawan, Y. A case-control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma. Hepatol. Int. 4, 577-584 (2010).
11. Sugauchi, F. et al. Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J. Med. Virol. 70, 537-544 (2003).
12. Fang, Z.-L. et al. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J. Gen. Virol. 89, 2882-2890 (2008).
13. Chen, C. H. et al. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology 133, 1466-1474 (2007).
14. Liu, S. et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J. Natl. Cancer Inst. 101, 1066-1082 (2009).
15. Fernandez, A. F. et al. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res. 19, 438-451 (2009).
16. Kaur, P. et al. DNA Methylation of Hepatitis B Virus (HBV) Genome Associated with the Development of Hepatocellular Carcinoma and Occult HBV Infection. J. Infect. Dis. 202, 700-704 (2010).
17. Vivekanandan, P., Thomas, D. & Torbenson, M. Hepatitis B viral DNA is methylated in liver tissues. J. Viral. Hepat. 15, 103-107 (2008).
18. Bartholomeusz, A. & Schaefer, S. Hepatitis B virus genotypes: comparison of genotyping methods. Rev. Med. Virol. 14, 3-16 (2004).
19. HE, B. Hepatitis B virus: significance of naturally occurring mutants. Intervirology 35, 40-50 (1993).
20. Zhang, Q., Wu, G., Richards, E., Jia, S. g. & Zeng, C. Universal primers for HBV genome DNA amplification across subtypes: a case study for designing more effective viral primers. Virol. J. 4, 92 (2007).
21. Block, T. M., Guo, H. & Guo, J.-T. Molecular Virology of Hepatitis B Virus for Clinicians. Clin. Liver. Dis. 11, 685-706 (2007).
22. Zhang, Y. et al. Comparative Analysis of CpG Islands among HBV Genotypes. PLoS ONE 8, e56711, doi:10.1371/journal. pone.0056711 (2013).
23. Moolla, N., Kew, M. & Arbuthnot, P. Regulatory elements of hepatitis B virus transcription. J. Viral. Hepat. 9, 323-331 (2002).
24. Kim, J. W. et al. Replicative Activity of Hepatitis B Virus Is Negatively Associated with Methylation of Covalently Closed Circular DNA in Advanced Hepatitis B Virus Infection. Intervirology 54, 316-325 (2011).
25. Guo, Y., Li, Y., Mu, S., Zhang, J. & Yan, Z. Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication. J Med Virol. 81, 1177-1183 (2009).
26. Zhang, X., Hou, J. & Lu, M. Regulation of Hepatitis B virus Replication by Epigenetic Mechanisms and MicroRNAs. Front Genet. 4, doi:10.3389/fgene.2013.00202 (2013).
27. Park, J. G. et al. Characterization of cell lines established from human hepatocellular carcinoma. Int J Cancer. 62, 276-282 (1995).
28. Su, T.-S. et al. Hepatitis B virus transcripts in a human hepatoma cell line, hep 3B. Biochem. Biophys. Res. Commun. 138, 131-138 (1986).
29. Jain, S. et al. Methylation of the CpG Sites Only on the Sense Strand of the APC Gene Is Specific for Hepatocellular Carcinoma. PLoS ONE 6, e26799, doi: 10.1371/journal.pone.0026799 (2011).
30. Vivekanandan, P., Daniel, H. D.-J., Kannangai, R., Martinez-Murillo, F. & Torbenson, M. Hepatitis B Virus Replication Induces Methylation of both Host and Viral DNA. J. Virol. 84, 4321-4329 (2010).
31. Jain, S. et al. Impact of the Location of CpG Methylation within the GSTP1 Gene on Its Specificity as a DNA Marker for Hepatocellular Carcinoma. PLoS ONE 7, e35789, doi:10.1371/journal.pone.0035789 (2012).
32. Moribe, T. et al. Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma. Int. J. Cancer 125, 388-397 (2009).
33. Chang, H. et al. Methylation of tumor associated genes in tissue and plasma samples from liver disease patients. Exp. Mol. Pathol. 85, 96-100 (2008).
34. Ramsahoye, B. H. et al. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl. Acad. Sci. U S A. 97, 5237-5242 (2000).
35. Guo, J. U. et al. Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat. Neurosci. 17, 215-222 (2014).
36. Xie, W. et al. Base-Resolution Analyses of Sequence and Parent-of-Origin Dependent DNA Methylation in the Mouse Genome. Cell 148, 816-831 (2012).
37. Lister, R. et al. Global Epigenomic Reconfiguration During Mammalian Brain Development. Science 341 (2013).
38. Kozlenkov, A. et al. Differences in DNA methylation between human neuronal and glial cells are concentrated in enhancers and non-CpG sites. Nucleic Acids Res. 42, 109-127 (2014).
39. Varley, K. E. et al. Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res. 23, 555-567 (2013).
40. Brooks, A. R. et al. Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. J. Gene. Med. 6, 395-404 (2004).
41. Dodge, J. E., Ramsahoye, B. H., Wo, Z. G., Okano, M. & Li, E. De novo methylation of MMLV provirus in embryonic stem cells: CpG versus non-CpG methylation. Gene. 289, 41-48 (2002).
42. Kim, K., Garner-Hamrick, P. A., Fisher C., Lee, D. & Lambert, P. F. Methylation Patterns of Papillomavirus DNA, Its Influence on E2 Function, and Implications in Viral Infection. J. Virol. 77, 12450-12459 (2003).
43. Kalantari, M. et al. Conserved Methylation Patterns of Human Papillomavirus Type 16 DNA in Asymptomatic Infection and Cervical Neoplasia. J. Virol. 78, 12762-12772 (2004).
44. Patil, V., Ward, R. L. & Hesson, L. B. The evidence for functional non-CpG methylation in mammalian cells. Epigenetics 9, 823-828 (2014).
45. Bill, C. A. & Summers, J. Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration. Proc. Natl. Acad. Sci. U S A. 101, 11135-11140 (2004).
46. Cai, D. et al. Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation. Antimicrob Agents Chemother. 56, 4277-4288 (2012).
47. Lin, S. Y. et al. A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine. J. Mol. Diagn. 13, 474-484 (2011).
48. Jain, S. et al. Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis. Hepatol Res. doi:10.1111/hepr.12449 (2014).